Feeds › Clinical trial updates
Clinical trial updates
Drug and device trials that companies register on ClinicalTrials.gov: newly completed phase 3 studies, changes of status and the dates a study is due to finish.
About this data
- What it is
- ClinicalTrials.gov is the US registry of clinical studies. Drug and device makers register their trials there and update the record as each study moves on. We list the studies that companies sponsor, and match the sponsor to a public company when the name lines up. The page opens on Phase 3 studies marked completed, the late-stage trials that come before a request for approval. Change View to see the changes of status we have noticed, or every recent update.
- Who files it
- The sponsor of the study, in its record on ClinicalTrials.gov. The registry is run by the US National Library of Medicine and does not check what sponsors report.
- How current
- We check the registry every day. Sponsors update records on their own schedule, from the same week to months later, so a change can appear in the registry well after it happened.
- Terms
- ClinicalTrials.govClinicalTrials.gov is the US government's registry of clinical studies, run by the National Library of Medicine. Sponsors register a study before it starts and update the record as it goes. The registry does not check what a sponsor reports.Phase 3The late stage of testing, usually with hundreds or thousands of people, to confirm that a treatment works and to find side effects. A study marked Phase 2/3 covers both stages.statusThe registry's own word for where a study stands: not yet recruiting, recruiting, active but not recruiting, completed, terminated (stopped early), withdrawn (never started), suspended, or unknown (the sponsor has not confirmed the record for a long time).completedThe sponsor has marked the study as finished. It says nothing about whether the treatment worked: results, if any, are reported separately and often later.status changesOur history of status changes starts the day we first stored each study, so a change made before that is not shown. The date is when we noticed the change, which can be later than when the sponsor made it.primary completionThe date the last participant is examined for the main question the study asks. The study can run on after it, for follow-up. Sponsors enter the date and revise it, and an estimated date can pass without an update.company matchWe match the sponsor's name to a public company automatically, and by hand for the large drugmakers. A subsidiary or a differently spelled name can be missed, so a study with no ticker does not mean the sponsor is private.
- Worth knowing
- A completed study is not a result: the registry says the study ended, not whether the treatment worked. Status changes start on the day we first stored each study, so earlier changes are not shown. Dates are the sponsor's own, and an estimated date can pass without an update. We match sponsors to companies automatically, with a hand-checked list for the large drugmakers, so a study with no ticker may still belong to a public company. This is information about studies, not a forecast of what they will show or of a stock's price.
- Not to be confused with
- FDA approvals and clearances: what the FDA decided, not what a sponsor reports about a study.
All of this comes from ClinicalTrials.gov, the US registry of clinical studies. We are not affiliated with it.
Source and freshness · Information, not investment advice (disclaimer).
Studies updated per day, last 30 days
All industry-sponsored studies Sponsor matched to a public company
By the day the sponsor last updated the study's record. A study updated twice counts once, on its latest day.
Latest clinical trial updates
Showing: ticker GMED · All recent updates
Studies by the date their record was last updated.
| Updated | Study | SponsorWe match the sponsor's name to a public company automatically, and by hand for the large drugmakers. A subsidiary or a differently spelled name can be missed, so a study with no ticker does not mean the sponsor is private. | PhaseThe late stage of testing, usually with hundreds or thousands of people, to confirm that a treatment works and to find side effects. A study marked Phase 2/3 covers both stages. | StatusThe registry's own word for where a study stands: not yet recruiting, recruiting, active but not recruiting, completed, terminated (stopped early), withdrawn (never started), suspended, or unknown (the sponsor has not confirmed the record for a long time). | Enrolled | Primary completionThe date the last participant is examined for the main question the study asks. The study can run on after it, for follow-up. Sponsors enter the date and revise it, and an estimated date can pass without an update. | Source |
|---|---|---|---|---|---|---|---|
| May 15, 2026 | A Retrospective Review: Outcomes of the REFLECT™ System for Idiopathic Scoliosis NCT07589023 · Idiopathic Scoliosis Scoliosis Correction System, Scoliosis Correction System | GMED Globus Medical Inc | — | Not yet recruiting | 100 | Jan 30, 2027 | Registry ↗ |
| Feb 13, 2026 | REFLECT Scoliosis System Post Approval Study NCT06298812 · Idiopathic Scoliosis REFLECT Scoliosis Correction System | GMED Globus Medical Inc | Not applicable | Recruiting | 100 | Mar 31, 2027 | Registry ↗ |
| Feb 23, 2023 | Amnios™ RT Outcomes Study NCT04088383 · Plantar Fasciitis Amnios™ RT, Saline | GMED Globus Medical Inc | Not applicable | Completed | 150 | Nov 30, 2022 | Registry ↗ |
| Oct 19, 2021 | Prospective Robotic Global Research Study (PROGRESS) NCT04257279 · Lumbar Disc Disease ExcelsiusGPS™ | GMED Globus Medical Inc | Not applicable | Unknown | 200 | Dec 2021 | Registry ↗ |
| Aug 23, 2021 | Patient Outcomes Using an Expandable Spacer NCT03162666 · Degenerative Disc Disease ALTERA | GMED Globus Medical Inc | — | Withdrawn | 0 | Nov 6, 2020 | Registry ↗ |
| Mar 15, 2021 | A Prospective Randomized Postmarket Clinical Study of the TRANSITION Stabilization System NCT02184520 · Acute Instabilities Thoracic, Lumbar and Sacral Spine, Chro… TRANSITION, REVERE | GMED Globus Medical Inc | Not applicable | Terminated | 1 | Oct 20, 2016 | Registry ↗ |
| Feb 3, 2021 | Study of an Expandable Interbody Device for the Lumbar Spine NCT02075554 · Degenerative Disc Disease CALIBER | GMED Globus Medical Inc | Not applicable | Completed | 58 | Nov 2016 | Registry ↗ |
| Sep 11, 2020 | Treatment of Sacroiliac Dysfunction With SI-LOK® Sacroiliac Joint Fixation SI-SI-LOK NCT01861899 · Joint Dysfunction SI-LOK | GMED Globus Medical Inc | — | Completed | 46 | Jul 5, 2018 | Registry ↗ |
| Sep 10, 2020 | A Pivotal Study of a Facet Replacement System to Treat Spinal Stenosis NCT00401518 · Lumbar Spinal Stenosis Non-randomized ACADIA® Facet Replacement System, Randomized… | GMED Globus Medical Inc | Not applicable | Completed | 390 | Aug 2017 | Registry ↗ |
| Aug 2, 2019 | Proximal Junctional Kyphosis Following Long Instrumented Spinal Fusion: The Effect of Implant Selec… NCT01441999 · Kyphosis Less rigid rod, Rigid Rod | GMED Globus Medical Inc | Not applicable | Withdrawn | 0 | Dec 2016 | Registry ↗ |
| Oct 2, 2018 | TRIUMPH Lumbar Artificial Disc IDE: A Pilot Study NCT01198470 · Lumbar Degenerative Disc Disease TRIUMPH® Lumbar Artificial Disc | GMED Globus Medical Inc | Not applicable | Completed | 20 | Dec 2016 | Registry ↗ |
| Jun 1, 2018 | Study Evaluating the Safety and Effectiveness of the FLEXUS(TM) Interspinous Spacer NCT01156675 · Lumbar Spinal Stenosis FLEXUS(TM) Interspinous Spacer, XSTOP® Interspinous Spacer | GMED Globus Medical Inc | Not applicable | Terminated | 215 | Jul 2015 | Registry ↗ |
| Feb 15, 2018 | Preliminary Investigation of ViaShield™ Amnion Patch as an Anti-Adhesive Barrier in Hemicraniectomi… NCT03371316 · Hemicraniectomies ViaShield | GMED Globus Medical Inc | Not applicable | Withdrawn | 0 | Jan 30, 2018 | Registry ↗ |
| Jun 9, 2017 | SECURE®-C Cervical Artificial Disc Clinical Study/ SECURE-C Cervical Artificial Disc Postmarket App… NCT00882661 · Symptomatic Cervical Disc Disease SECURE-C Cervical Artificial Disc, ASSURE Cervical plate an… | GMED Globus Medical Inc | Not applicable | Completed | 380 | Apr 2010 | Registry ↗ |
| Aug 10, 2016 | A Retrospective Study Using CALIBER® TLIF Expandable Spacer in the Treatment of DDD: 2 Year Follow-… NCT02388022 · Degenerative Disc Disease Degenerative Disc Disease | GMED Globus Medical Inc | — | Completed | 200 | Jan 2015 | Registry ↗ |
| Aug 10, 2016 | INDEPENDENCE Spacer for Lumbar Fusion NCT02299323 · Degenerative Disc Disease INDEPENDENCE | GMED Globus Medical Inc | — | Completed | 30 | Aug 2016 | Registry ↗ |
16 items, most recent first (up to 50). Each row links to the study's page on ClinicalTrials.gov. Updated Nov 15, 2026, 8:20 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · FDA approvals and clearances